These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35213814)

  • 41. Coinfection with severe acute respiratory syndrome coronavirus-2 and other respiratory viruses at a tertiary hospital in Korea.
    Kim Z; Lee JH
    J Clin Lab Anal; 2021 Aug; 35(8):e23868. PubMed ID: 34273182
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical profile and containment of the Ebola virus disease outbreak in two large West African cities, Nigeria, July-September 2014.
    Ohuabunwo C; Ameh C; Oduyebo O; Ahumibe A; Mutiu B; Olayinka A; Gbadamosi W; Garcia E; Nanclares C; Famiyesin W; Mohammed A; Nguku P; Koko RI; Obasanya J; Adebayo D; Gbadegesin Y; Idigbe O; Oguntimehin O; Nyanti S; Nzuki C; Abdus-Salam I; Adeyemi J; Onyekwere N; Musa E; Brett-Major D; Shuaib F; Nasidi A
    Int J Infect Dis; 2016 Dec; 53():23-29. PubMed ID: 27575939
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Field Evaluation of Capillary Blood Samples as a Collection Specimen for the Rapid Diagnosis of Ebola Virus Infection During an Outbreak Emergency.
    Strecker T; Palyi B; Ellerbrok H; Jonckheere S; de Clerck H; Bore JA; Gabriel M; Stoecker K; Eickmann M; van Herp M; Formenty P; Di Caro A; Becker S
    Clin Infect Dis; 2015 Sep; 61(5):669-75. PubMed ID: 25991465
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serosurveillance of viral pathogens circulating in West Africa.
    O'Hearn AE; Voorhees MA; Fetterer DP; Wauquier N; Coomber MR; Bangura J; Fair JN; Gonzalez JP; Schoepp RJ
    Virol J; 2016 Oct; 13(1):163. PubMed ID: 27716429
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparative study on the efficiency of commercial reverse transcriptase-Polymerase chain reaction kits for the detection of severe acute respiratory syndrome coronavirus 2 infections.
    Ramalingam G; Dhanasezhian A; Murugesan A; Saminathan G; Sivathanu L
    Indian J Public Health; 2022; 66(3):276-281. PubMed ID: 36149104
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area.
    Barry M; AlMohaya A; AlHijji A; Akkielah L; AlRajhi A; Almajid F; Alsharidi A; Al-Shahrani FS; Alotaibi NH; Alanazi A; Ghonem L; Alhetheel A; Alsubaie S; Memish ZA
    J Epidemiol Glob Health; 2020 Sep; 10(3):214-221. PubMed ID: 32954712
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of a point-of-care blood test for identification of Ebola virus disease at Ebola holding units, Western Area, Sierra Leone, January to February 2015.
    Walker NF; Brown CS; Youkee D; Baker P; Williams N; Kalawa A; Russell K; Samba AF; Bentley N; Koroma F; King MB; Parker BE; Thompson M; Boyles T; Healey B; Kargbo B; Bash-Taqi D; Simpson AJ; Kamara A; Kamara TB; Lado M; Johnson O; Brooks T
    Euro Surveill; 2015 Mar; 20(12):. PubMed ID: 25846490
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lassa virus RNA detection from suspected cases in Nigeria, 2011-2017.
    Babalola SO; Babatunde JA; Remilekun OM; Amaobichukwu AR; Abiodun AM; Jide I; Adeshina AI; Chikwe I; Aremu OS
    Pan Afr Med J; 2019; 34():76. PubMed ID: 31819792
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of severe COVID-19 patient with negative RT-PCR for SARS-CoV-2: Role of clinical, radiological, and serological diagnosis.
    Soedarsono S; Febriani A; Hasan H; Widyoningroem A
    Radiol Case Rep; 2021 Jun; 16(6):1405-1409. PubMed ID: 33815639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical characteristics of 154 patients suspected of having Ebola virus disease in the Ebola holding center of Jui Government Hospital in Sierra Leone during the 2014 Ebola outbreak.
    Yan T; Mu J; Qin E; Wang Y; Liu L; Wu D; Jia H; Li Z; Guo T; Wang X; Qin Y; Li Y; Chen S; Zhang Y; Zhang J; Wu Y; Wang S; Li J
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2089-95. PubMed ID: 26223324
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever.
    Liu CL; Lu YT; Peng MJ; Chen PJ; Lin RL; Wu CL; Kuo HT
    Chest; 2004 Aug; 126(2):509-17. PubMed ID: 15302738
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Co-infection of Coronavirus Disease 2019 and Influenza A: A Report from Iran.
    Khodamoradi Z; Moghadami M; Lotfi M
    Arch Iran Med; 2020 Apr; 23(4):239-243. PubMed ID: 32271596
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Double-quencher probes improve detection sensitivity toward Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a reverse-transcription polymerase chain reaction (RT-PCR) assay.
    Hirotsu Y; Mochizuki H; Omata M
    J Virol Methods; 2020 Oct; 284():113926. PubMed ID: 32650037
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of Ebola virus disease on maternal health service utilisation and perinatal outcomes in West Africa: a systematic review.
    Kassa ZY; Scarf V; Fox D
    Reprod Health; 2022 Feb; 19(1):35. PubMed ID: 35120540
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early onset of neurological features differentiates two outbreaks of Lassa fever in Ebonyi state, Nigeria during 2017-2018.
    Chika-Igwenyi NM; Harrison RE; Psarra C; Gil-Cuesta J; Gulamhusein M; Onwe EO; Onoh RC; Unigwe US; Ajayi NA; Nnadozie UU; Ojide CK; Nwidi DU; Ezeanosike O; Sampson E; Adeke AS; Ugwu CN; Anebonam U; Tshiang JK; Maikere J; Reid A
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009169. PubMed ID: 33684118
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lessons learned by surveillance during the tail-end of the Ebola outbreak in Guinea, June-October 2015: a case series.
    Keïta M; Conté F; Diallo B; Lufwa D; Katomba J; Snacken R; Pallawo R; Tolno A; Diallo AB; Djingarey MH; Subissi L
    BMC Infect Dis; 2017 Apr; 17(1):304. PubMed ID: 28438127
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Review of Ebola virus disease in children - how far have we come?
    Dixit D; Masumbuko Claude K; Kjaldgaard L; Hawkes MT
    Paediatr Int Child Health; 2021 Feb; 41(1):12-27. PubMed ID: 32894024
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 2017 Outbreak of Ebola Virus Disease in Northern Democratic Republic of Congo.
    Nsio J; Kapetshi J; Makiala S; Raymond F; Tshapenda G; Boucher N; Corbeil J; Okitandjate A; Mbuyi G; Kiyele M; Mondonge V; Kikoo MJ; Van Herp M; Barboza P; Petrucci R; Benedetti G; Formenty P; Muyembe Muzinga B; Ilunga Kalenga O; Ahuka S; Fausther-Bovendo H; Ilunga BK; Kobinger GP; Muyembe JT
    J Infect Dis; 2020 Feb; 221(5):701-706. PubMed ID: 30942884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.